TELMISARTAN 40mg. IP + CHLORTHALIDONE 6.25mg. IP + CILNIDIPINE 10mg. IP

An antihypertensive agent to treat high blood pressure in patients whose blood pressure is not adequately controlled with monotherapy of cilnidipine/telmisartan/chlorthalidone or dual therapy. Relaxes blood vessels, reduces fluid retention, and lowers blood pressure effectively. Relaxes and widens blood vessels and improves the blood flow and oxygen supply to the heart. Promotes increased urine production and eliminates excess fluid from the body. Produces slightly greater reductions in blood pressure compared with hydrochlorothiazide. (Springer, 2015) Exhibits promising potential in decreasing the risk of cardiovascular events among high-risk patients. (Philippe R Akhrass, 2011) An effective strategy for the treatment of hypertension and related complications. (Jun-Hwan Jo, 2021) A favorable choice in hypertension therapy that manages high blood pressure and prevents cardiovascular events. (Albertus J Kooter, 2010) Significantly reduces systolic blood pressure, diastolic blood pressure, and pulse rate in hypertensive patients. (Rabindra Nath Chakraborty, 2021)